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Background: In contrast to mammals, the zebrafish has the remarkable capacity to regenerate its pancreatic beta
cells very efficiently. Understanding the mechanisms of regeneration in the zebrafish and the differences with
mammals will be fundamental to discovering molecules able to stimulate the regeneration process in mammals. To
identify the pancreatic cells able to give rise to new beta cells in the zebrafish, we generated new transgenic lines
allowing the tracing of multipotent pancreatic progenitors and endocrine precursors.
Results: Using novel bacterial artificial chromosome transgenic nkx6.1 and ascl1b reporter lines, we established that
nkx6.1-positive cells give rise to all the pancreatic cell types and ascl1b-positive cells give rise to all the endocrine
cell types in the zebrafish embryo. These two genes are initially co-expressed in the pancreatic primordium and
their domains segregate, not as a result of mutual repression, but through the opposite effects of Notch signaling,
maintaining nkx6.1 expression while repressing ascl1b in progenitors. In the adult zebrafish, nkx6.1 expression
persists exclusively in the ductal tree at the tip of which its expression coincides with Notch active signaling in
centroacinar/terminal end duct cells. Tracing these cells reveals that they are able to differentiate into other ductal
cells and into insulin-expressing cells in normal (non-diabetic) animals. This capacity of ductal cells to generate
endocrine cells is supported by the detection of ascl1b in the nkx6.1:GFP ductal cell transcriptome. This
transcriptome also reveals, besides actors of the Notch and Wnt pathways, several novel markers such as id2a.
Finally, we show that beta cell ablation in the adult zebrafish triggers proliferation of ductal cells and their
differentiation into insulin-expressing cells.
Conclusions: We have shown that, in the zebrafish embryo, nkx6.1+ cells are bona fide multipotent pancreatic
progenitors, while ascl1b+ cells represent committed endocrine precursors. In contrast to the mouse, pancreatic
progenitor markers nkx6.1 and pdx1 continue to be expressed in adult ductal cells, a subset of which we show are
still able to proliferate and undergo ductal and endocrine differentiation, providing robust evidence of the existence of
pancreatic progenitor/stem cells in the adult zebrafish. Our findings support the hypothesis that nkx6.1+ pancreatic
progenitors contribute to beta cell regeneration. Further characterization of these cells will open up new perspectives
for anti-diabetic therapies.
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The pancreas is composed of an exocrine compartment
with acinar and ductal cells, which secrete and transport
digestive enzymes into the gut, and an endocrine compart-
ment, which regulates glucose homeostasis by secreting
pancreatic hormones into the bloodstream. Loss of pan-
creatic insulin-producing cells (beta cells) is a hallmark of
diabetes. An attractive therapeutic approach to cure this
disease is to stimulate beta cell regeneration in vivo from
another pancreatic cell type or from progenitors. However,
the regenerative capacity of beta cells is very limited in
mammals and the cellular and molecular mechanisms
involved need to be well understood before we will be able
to stimulate this process. The zebrafish (Danio rerio),
owing to its phenomenal capacity to restore beta cells
after targeted cell ablation [1–3], has become an attractive
model organism for the study of the regeneration process.
To this end, tools need to be developed, especially to
define the source of the new beta cells. So far, no zeb-
rafish transgenic lines have been available to allow a
lineage tracing of either multipotent pancreatic pro-
genitors, giving rise to both exocrine and endocrine
tissues, or pancreatic endocrine precursor cells.
The pancreas develops from two domains, called the
dorsal bud and the ventral bud, which emerge from the
foregut endoderm [4, 5]. In zebrafish, the dorsal bud
generates the first wave of endocrine cells, which cluster
at 24 hours post fertilization (hpf ) to form the principal
islet [6]. The ventral bud emerges anteriorly to the dor-
sal bud at 32 hpf and gives rise to acinar, ductal, and to
a second wave of endocrine cells [4, 7, 8]. These late
endocrine cells originate either from the extra-
pancreatic ducts (EPDs) and contribute to the expansion
of the principal islet [9–11] or from the intra-pancreatic
ducts (IPDs) and form small secondary islets all along
them. These IPDs contain pancreatic Notch-responsive
cells (PNCs), which represent a population of progeni-
tors of endocrine cells and ductal cells but not of acinar
cells [7, 12].
Notch signaling pathway controls the differentiation of
pancreatic cells both in zebrafish and mice (reviewed by
[13]). One of its functions is to maintain a pool of
progenitors in an undifferentiated state through the re-
pression of genes of the achaete scute-like (ASCL) family
or of the atonal-related protein (ARP) family. In the
murine pancreas, Notch signaling prevents endocrine
cell differentiation through the repression of neurog3
[14]. In zebrafish, neurog3 is not expressed in the
pancreas and therefore the control of endocrine cell fate
is fulfilled by other ASCL/ARP factors, namely Ascl1b
and Neurod1, which are both repressed by Notch signal-
ing [15]. Exactly like the inactivation of murine Neurog3,
their simultaneous inactivation completely prevents
endocrine cell differentiation leading to the loss of allhormone-secreting cells [15]. ascl1b is the earliest
pancreatic marker identified during zebrafish develop-
ment, its expression starting at the end of gastrulation in
the prospective pancreatic region (10 hpf). ascl1b is
transiently expressed during the formation of the dorsal
bud (10–17 hpf ) and, like murine Neurog3, is not
detected in hormone-expressing cells. Later, in the
ventral bud, ascl1b expression is turned on when the
endocrine cell differentiation program is induced
through the blocking of Notch signaling [7, 12, 16].
This Notch inactivation triggers a massive expression
of ascl1b in IPDs [15]. These data suggest that ascl1b
expression is restricted to the committed endocrine
precursors. However, the observation that the onset
of ascl1b expression in the prospective pancreatic
region precedes all other known pancreatic progenitor
markers raises the possibility of the multipotency of
the first ascl1b+ cells.
Another key factor for pancreatic development is the
homeobox transcription factor Nkx6.1. In the mouse, it
is expressed in the multipotent progenitors during early
pancreatic development [17], and, in the zebrafish,
nkx6.1 is expressed early in the pancreatic primordium
of the dorsal bud (from 11.5 hpf onwards) [18]. At later
developmental stages in the mouse embryo, Nkx6.1
becomes restricted to the endocrine/duct bipotential
trunk domain [19]. Similarly, nkx6.1 is first broadly
expressed in the zebrafish pancreatic ventral bud prim-
ordium [20], then segregates from the ptf1a+ acinar cells
to persist in the primitive ducts [20–22] that will give
rise to the mature ducts and to secondary islets [7]. In
the mouse, Nkx6.1 is expressed in the differentiated beta
cells [23] while in the zebrafish, nkx6.1 is never expressed
in beta cells nor in the other pancreatic hormone-
expressing cells [18]. These data suggest that in zebrafish
nkx6.1 also marks multipotent pancreatic progenitors.
However, previous findings suggested that the early
ventral bud primordium was composed of a heteroge-
neous population of pancreatic cells comprising Notch-
responsive cells, giving rise to ductal and endocrine cells,
separated from the ptf1a+ cells, which generate the acinar
cells [7]. This study raises the question of the identity of
the multipotent pancreatic progenitors in the zebrafish
ventral pancreatic bud and its derivatives.
Here, we show that nkx6.1 labels multipotent pan-
creatic progenitors giving rise to all of the different
pancreatic cell types (endocrine, ductal, and acinar)
while ascl1b marks endocrine precursors leading to
the different endocrine cell types. For this purpose, we
have generated two novel bacterial artificial chromosome
(BAC) transgenic nkx6.1 and ascl1b reporter lines,
Tg(nkx6.1:eGFP) and Tg(ascl1b:eGFP-2A-creERT2), that both
faithfully recapitulate the expression of the nkx6.1 and
ascl1b endogenous genes. Using these novel transgenic
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between these two factors and their relationship with the
Notch signaling pathway. We also demonstrate that nkx6.1
expression persists in the adult ductal tree, notably in the
centroacinar/terminal end duct cells (CACs), for which we
show that they are able to differentiate into insulin-
expressing cells in vivo. By isolating nkx6.1:eGFP+ cells
from the dissected pancreases of adult fish, we determined
the transcriptome of adult pancreatic ductal cells, which
revealed the expression of several regulatory genes poten-
tially involved in endocrine regeneration. Finally, we
provide evidence that regenerating beta cells also originate
from ductal cells.
Results
The bacterial artificial chromosome reporter
Tg(nkx6.1:eGFP) recapitulates in vivo the expression of
the endogenous nkx6.1 gene
To label the nkx6.1-expressing cells, we generated a
transgenic line driving the expression of the enhanced
green fluorescent protein (eGFP) under the control of
nkx6.1 regulatory regions. We engineered a BAC span-
ning from 55 kb upstream to 95 kb downstream of the
nkx6.1 gene and inserted the eGFP coding regions into
exon 1, replacing the beginning of the nkx6.1 open read-
ing frame (Additional file 1: Fig. S1A). This BAC
reporter construct was introduced into the zebrafish
genome using the Tol2 transposon system [24, 25] and
the stable transgenic line Tg(nkx6.1:eGFP) obtained
showed expression of green fluorescent protein (GFP) in
the nervous system and in the pancreas, which mirrors
the endogenous Nkx6.1 protein expression (Additional
file 1: Fig. S1B). Detailed comparison of the localization
of these two proteins in the pancreas during develop-
ment confirmed that GFP is indeed co-expressed with
Nkx6.1 (Fig. 1). Indeed, together with the endogenous
Nkx6.1 protein [18], GFP is expressed at the base of the
endocrine islet at 24 and 30 hpf (Fig. 1b, c), in the
ventral bud at 38 and 48 hpf (Fig. 1d, e), and in IPDs
and EPDs at 4 days post fertilization (dpf ) (Fig. 1f, f'). In
contrast, at earlier stages, GFP was detected in a subset
of Nkx6.1+ cells, probably due to the delay of GFP
expression compared to Nkx6.1. Indeed, at 17 hpf, about
75 % of the Nkx6.1+ cells showed detectable GFP
expression (Fig. 1a, a') and at 14 hpf, this proportion
dropped even further to about 25–30 % (data not
shown). Conversely, a few hours after the onset of
nkx6.1 gene expression, some GFP+/Nkx6.1– cells were
also detected (green arrows, Fig. 1b'–e'). This GFP label-
ing is not the result of an ectopic expression of the gfp
transcript, as double fluorescent whole-mount in situ
hybridization (WISH) showed that the gfp transcripts
are present in the same pancreatic domain as nkx6.1
transcripts (data not shown) and importantly, likenkx6.1, gfp transcripts were not found in hormone-
expressing cells (Additional file 1: Fig. S1C–C'', D–D'').
Hence, prolonged GFP detection is rather due to the
well-known high stability of GFP (±24 h half-life [26]),
which persists in cells where Nkx6.1 protein is no longer
found. This is nicely illustrated at 30 hpf, where strong
GFP expression is detected at the base of the forming
islet where Nkx6.1+ pancreatic progenitors are located,
while weak GFP labeling is found dorsally within the
islet, where differentiated endocrine cells, devoid of
Nkx6.1, are clustered (Fig. 1c). As expected, this
prolonged GFP detection will gradually fade away, finally
to disappear completely in the differentiated endocrine
cells (Fig. 1f ).
The high stability of GFP allowed us to perform short-
term lineage tracing to follow the immediate progeny
arising from nkx6.1+ cells.
nkx6.1-expressing cells are multipotent progenitors
giving rise to all pancreatic cell lineages
Using short-term lineage tracing, we first assessed if
nkx6.1+ cells can give rise to the first wave of endocrine
cells of the dorsal bud using the Isl1 marker, which
labels all mature endocrine cells. In contrast to the
endogenous nkx6.1 and the nkx6.1:GFP transcripts,
which are not co-expressed with isl1 ([18] and Additional
file 1: Fig. S1D–D"), GFP was detected in 40 ± 3.8 % of
Isl1+ cells in Tg(nkx6.1:eGFP) embryos (n = 10) at 30 hpf
indicating that nkx6.1 cells can give rise to endocrine cells
(Fig. 2a–a"). Also, we found GFP in all different endo-
crine cell types, i.e. in 35 ± 18.8 % of insulin+ (Ins+)
cells (n = 21) (Fig. 2b–b''), 42 ± 12.5 % somatostatin+ (Sst+)
cells (n = 4) (Fig. 2c–c"), and 77 ± 3.7 % of glucagon+
(Gcg+) cells (n = 5) (Fig. 2d–d"). The percentage of
GFP+ cells in the different endocrine subtypes appeared
to depend on the onset of expression for each hormone,
which is from 15 hpf onward for ins, 17 hpf for sst2
and 21 hpf for gcga. Therefore, when the first
hormone-expressing cells differentiate from the pool of
nkx6.1+ progenitors, only a minority of them have
accumulated enough GFP to be detected, as explained
above (see Fig. 1a and data not shown).
Next, we analyzed whether the nkx6.1+ cells also
contribute to the cells originating from the ventral bud
(ductal, acinar, and secondary islets). With Nkx6.1 being
expressed in all pancreatic ductal cells (as shown in
Fig. 1e), we detected accordingly an expression of GFP
in all pancreatic ducts labeled by 2F11 antibody (Fig. 2f, f').
In contrast, while endogenous nkx6.1 never co-localizes
with trypsin (data not shown), a marker of mature
acinar cells, GFP was detected in a large majority of ac-
inar cells at 55 hpf (70 ± 25 % of trypsin+ cells (n = 8)),
the stage when acinar cells have just begun to differen-
tiate (Fig. 2e, e'). Here again, the prolonged GFP
Fig. 1 The bacterial artificial chromosome reporter line Tg(nkx6.1:eGFP) mirrors the expression of the endogenous nkx6.1 gene. Immunodetection
of endogenous Nkx6.1 (red) and GFP (green) in Tg(nkx6.1:eGFP) embryos of the indicated stages. Green arrows point to Nkx6.1–/GFP+ cells and red arrows to
Nkx6.1+/GFP- cells. All views are either lateral (b, b', c, and c') or ventral (a, a', d, d', f, and f') with the anterior part to the left. They represent either z-plane
confocal images (b, d, e) or confocal projection images (a, c, f). Scale bars = 30 μm. EPD extra-pancreatic duct, IPD intra-pancreatic duct, i islet
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Fig. 2 (See legend on next page.)
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Fig. 2 nkx6.1-expressing cells give rise to all pancreatic cell types. a–d" Immunodetection in 30-hpf Tg(nkx6.1:eGFP) embryos of GFP with Isl1 (a–a"),
Ins (b–b"), Sst (c–c"), or Gcg (d–d"). Yellow arrows point to cells co-expressing GFP and the respective hormones. e–e" Fluorescent whole-mount in situ
hybridization (WISH) of 55-hpf Tg(nkx6.1:eGFP) embryos using a try probe followed by GFP immunodetection. f, f' Immunodetection in 5-dpf Tg(nkx6.1:eGFP)
embryos of GFP and of the hepato-pancreatic duct marker 2F11. g–h' Immunodetection of GFP and of Ins, Gcg, and Sst hormones in 5-dpf Tg(nkx6.1:eGFP)
embryos treated from 3 to 5 dpf with dimethyl sulfoxide (DMSO) (g) or with the Notch signaling inhibitor, LY411575 (h). Yellow arrows point to secondary
endocrine GFP+/hormones+ cells found in IPDs. All views are ventral with the anterior part to the left and represent either z-plane confocal images (a-e)
or confocal projection images (f-h). Scale bars = 20 μm (a-e) or 40 μm (f-h)
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from 3 dpf, the acinar cells are no longer labeled with
GFP (shown at 5 dpf in Fig. 2f'). And finally, to deter-
mine whether nkx6.1+ cells can give rise to the
secondary islets, emerging from IPDs, we treated
Tg(nkx6.1:eGFP) larvae with the Notch-signaling
inhibitor LY411575 from 3 to 5 dpf to increase the
number of late endocrine cells and thereby facilitate
their detection [7, 12, 16]. In LY411575-treated larvae,
we observed an increase of the endocrine cells in the
principal islet and the appearance of numerous endocrine
cells in the pancreatic tail (yellow arrows, Fig. 2h, h'), as
previously reported. All these endocrine cells are co-
labeled with GFP (n = 4) indicating that the nkx6.1+
ductal cells can also give rise to the secondary islets.
These data indicate that nkx6.1-expressing cells are
multi-lineage pancreatic progenitors, which can differ-
entiate into endocrine, acinar, and ductal cells.
ascl1b-expressing cells give rise exclusively to the
endocrine lineage
To determine whether ascl1b is expressed in the multipo-
tent pancreatic progenitors or in the endocrine precursors,
we determined the cell fate of the ascl1b-expressing cells.
To that end, a BAC reporter Tg(ascl1b:eGFP-2A-creERT2)
was engineered where the bicistronic transcript eGFP-
2A-creERT2 is under the control of the promoter and
regulatory sequences of ascl1b. Thus, we replaced the
beginning of the ascl1b open reading frame with an
eGFP-2A-creERT2 cassette (Additional file 2: Fig. S2A).
The expression profile of GFP in the stable transgenic
line Tg(ascl1b:eGFP-2A-creERT2) faithfully recapitulates
the expression of the endogenous ascl1b transcript
(Additional file 2: Fig. S2B–D).
Cell fate experiments were performed with Cre/loxP-
based lineage tracing approaches by crossing the
Tg(ascl1b:eGFP-2A-creERT2) with Cre-responder trans-
genic lines, either Tg(ubi:loxP-AmCyan-loxP-ZsYellow),
termed Tg(ubi:CSY) [27], or Tg(ubi:loxP-eGFP-LoxP-
mCherry), termed Tg(ubi:Switch) [28] (Fig. 3a). The
double-transgenic embryos were treated five times with
4-hydroxytamoxifen (4OHT) from 11 to 15 hpf, the
period when ascl1b expression reaches its maximal
level [15], and the embryos were analyzed at 48 or 72
hpf. With these five 4OHT treatments, many ascl1b-expressing cells have undergone CRE recombination
while no recombination was detected in the treated
single-transgenic embryos used as control (data not
shown). The CRE-mediated recombination (rec) marker
(standing for either ZsYellow or mCherry) analyzed in
double-transgenic embryos at 48 hpf was detected in
38 ± 4.3 % of Isl1+ cells (n = 5), indicating that ascl1b+
cells give rise to the endocrine cells of the dorsal bud
(Fig. 3b–b"). In a similar way, the rec marker was detected
in 58 ± 7.1 % of the Ins+ cells (n = 9) (Fig. 3c–c") and in
59 ± 3.7 % of the Gcg+ cells (n = 9) (Fig. 3d–d"). In
contrast, the rec marker, clearly visible in the endocrine
islet, was not detected at 72 hpf in the ductal cells, labeled
by Nkx6.1, nor in the acinar cells, which surround them
(Fig. 3e, e'), indicating that ascl1b+ cells cannot give rise
to exocrine cells. Finally, we determined whether the
ascl1b+ cells give rise to the secondary islets emerging
from IPDs, either artificially induced by inhibiting the
Notch pathway or naturally occurring in 20-dpf larvae. As
the combined treatment of LY411575 with 4OHT was
lethal, we performed short-term lineage tracing based on
GFP expression (instead of Cre/loxP-based lineage tracing
analyses). As shown in Fig. 3f, g, LY411575 treatment
from 3 to 5 days of the Tg(ascl1b:eGFP-2A-creERT2) larvae
led to the appearance of GFP cells all along the IPDs, most
of these cells being also positive for glucagon or insulin
hormones (yellow arrows, Fig. 3g, g'), indicating that
ascl1b+ cells give rise to induced secondary islets. To trace
the naturally occurring endocrine cells, we treated
Tg(ascl1b:eGFP-2A-creERT2); Tg(ubi:Switch) larvae with
4OHT at 13, 14, and 17 dpf and analyzed the larvae at 20
dpf. The rec marker was detected within the principal islet
(Fig. 3h, h') as well as in secondary islets (Fig. 3i, i') con-
firming that ascl1b+ cells can give rise to secondary islets.
In conclusion, our data demonstrate that ascl1b+ cells
exclusively give rise to the endocrine cells originating
from both the dorsal and ventral buds.
nkx6.1 and ascl1b are first co-expressed in the endocrine
precursors of the dorsal bud but rapidly their expression
domain segregates
As presented above, nkx6.1 is expressed in the multipo-
tent pancreatic progenitors and ascl1b in the endocrine
precursors; we therefore analyzed the relationship
between these two populations by comparing the Nkx6.1
Fig. 3 (See legend on next page.)
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Fig. 3 ascl1b-expressing cells give rise exclusively to endocrine cells of both dorsal and ventral bud. a–e', h–i' Genetic lineage tracing using the
Cre-loxP system. a Schematic representation of the genetic lineage tracing experiments. The transgenic line Tg(ascl1b:eGFP-creERT2) was crossed
with the Tg(ubi:loxP-eGFP-loxP-mCherry) line, abbreviated Tg(ubi:Switch), or with the Tg(ubi:loxP-AmCyan-loxP-ZsYellow) line, abbreviated Tg(ubi:CSY),
treated with 4-hydroxytamoxifen (4OHT) at 11, 12, 13, 14, and 15 hpf (b–e') or at 13, 14, and 17 dpf (h–i') and fixed for analysis at the indicated
times. Black triangles in a represent loxP sites. b–e' Immunodetection of CRE-mediated rec markers (ZsYellow or mCherry, red) and Isl1 (b–b"), Ins
(c–c"), Gcg (d–d"), or Nkx6.1 (e, e') in 4OHT-treated embryos (green). The dotted white line delimits the pancreas (e'). Yellow arrows point to cells
co-expressing rec marker (ZsYellow or mCherry) and the respective hormones (Ins or Gcg). f–g' Short-term lineage tracing: immunodetection of GFP
and the Ins and Gcg hormones in 5-dpf Tg(ascl1b:eGFP-creERT2) embryos treated from 3 to 5 dpf with DMSO (f, f') or with the Notch signaling inhibitor,
LY411575 (g, g'). Yellow arrows in g' point to GFP+/Ins+/Gcg+ secondary endocrine cells found in the IPDs. h–i' Immunodetection at 20 dpf of the
CRE-mediated rec marker mCherry together with Ins and Gcg in 4OHT-treated larvae. All views are ventral with the anterior part to the left and represent
z-plane confocal images (b–d") or confocal projection images (e–i'). Scale bars = 20 μm
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At 14 hpf, the ascl1b:eGFP cells delineate two lines adjacent
to the midline (Fig. 4a–a"). These cells correspond to the
most medial endodermal cells (indicated by M in Fig. 4a'),
reported to give rise mostly to pancreatic endocrine cells
[29, 30]. At this stage, all of these ascl1b:eGFP cells also
express Nkx6.1. In contrast, the Nkx6.1 expression
domain is larger and, in addition to its expression in
the hypochord (indicated by H in Fig. 4a), it is also
expressed in the lateral cells, reported to give rise to
exocrine and intestinal cells [29]. Rapidly, these two
domains segregate since, as early as 1 hour later, the
majority of ascl1b:eGFP+ cells no longer express
Nkx6.1 (Fig. 4b–b"). Thus, separation of the two do-
mains is largely completed when hormone-expressing
cells start differentiating.
To determine whether such segregation results from a
mutual repression, we examined whether the loss of
ascl1b leads to an increase of nkx6.1 expression and vice
versa. We generated ascl1b and nkx6.1 loss-of-function
mutants using the CRISPR/cas9 genome editing technol-
ogy [31] (see “Methods” and Additional file 3: Fig. S3A, A'Fig. 4 nkx6.1 and ascl1b are first co-expressed in the endocrine precursors
Immunodetection of endogenous Nkx6.1 and GFP in Tg(ascl1b:eGFP-creERT2
the anterior part to the left and represent confocal projection images. Scaleand Additional file 4: Fig. S4A, A'). As shown in
Additional file 3: Fig. S3, the loss of ascl1b does not affect
the expression of nkx6.1 (Additional file 3: Fig. S3D, E)
while it significantly reduces the number of sst2+ cells
(Additional file 3: Fig. S3B, C), as reported for the
ascl1b morphants [15]. In the same way, ascl1b ex-
pression does not increase in nkx6.1 loss-of-function
mutant embryos (Additional file 4: Fig. S4F, G), for
which the effective loss of nkx6.1 expression was
confirmed by immunodetection of Nkx6.1 (Additional
file 4: Fig. S4B, C) and by the drastic reduction in the
number of Gcg+ cells (Additional file 4: Fig. S4D, E),
as reported for the nkx6.1 morphants [18].
ascl1b and nkx6.1 are regulated in an opposite way by
the Notch signaling pathway
We then tested whether the segregation of the ascl1b
and nkx6.1 expression domains results from a different
response to the Delta/Notch signaling pathway. To
analyze the impact of Notch signaling on nkx6.1 and
ascl1b expression, we performed Notch loss- and gain-
of- function analyses. We first analyzed the expressionof the dorsal bud but rapidly their expression domain moves apart.
) embryos at 14 hpf (a–a") and 15 hpf (b–b"). All views are ventral with
bars = 40 μm. H hypochord, M medial cells
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in which Notch signaling is disrupted [32]. As previously
reported [15], expression of ascl1b is strongly increased
in mib embryos at 15 hpf (Fig. 5a, b), in both the
pancreas and the nervous system. The opposite effect
was observed for nkx6.1 whose expression is reduced at
the same stage (Fig. 5c, d) and completely lost at 18 hpf
(Fig. 5e, f ). This suggests that the Notch signaling
pathway is essential for maintaining nkx6.1 expression
but not for its initiation. This was confirmed by the
finding that, at 13 hpf, nkx6.1 expression was unchanged
in mib mutants while ascl1b was already upregulated
(Additional file 5: Fig. S5A–D).
The same conclusion was drawn for the ventral bud
where treatment for 3–5 dpf with the LY411575 Notch
inhibitor led to a complete loss of Nkx6.1 expression
and a drastic increase of ascl1b:eGFP at 5 dpf (Fig. 5g, h).
Like the dorsal bud, the initiation of nkx6.1 expression in
the ventral bud is not dependent on Notch signaling as its
expression at 34 hpf was not perturbed in the mib mutant
(Additional file 5: Fig. S5E, F).
For gain-of-function approaches, we crossed the
Tg(hsp70:Gal4) with Tg(UAS:NICD) [33] and heat-
shocked the embryos at 11 hpf to overexpress the Notch
intracellular domain (NICD). At 3 hours after the heat-
shock, we observed a complete loss of ascl1b expression
(Fig. 5i, j) concomitant with an increase of nkx6.1 in the
NICD overexpressed embryos (Fig. 5k, l). This increase
was even more important at 30 hpf, when a drastic
expansion in the number of nkx6.1+ cells was observed
in the embryos overexpressing NICD (Fig. 5n) compared
to the control (Fig. 5m).
In conclusion, these data show that Notch signaling
represses ascl1b expression while it is essential for main-
taining nkx6.1 expression. By contrast, the initiation of
nkx6.1 expression is independent of Notch activity, both
in the dorsal and the ventral buds.
Most, but not all, Nkx6.1+ cells are Notch-responsive cells
nkx6.1 being dependent on Notch signaling for main-
taining its own expression, this prompted us to compare
the location of the Notch-responsive cells and the
Nkx6.1+ cells using the Tg(Tp1:VenusPest) [16] or
Tg(Tp1:eGFP) [12] lines in which fluorescent markers
are under the control of Notch-responsive elements
(Tp1). In the prospective dorsal bud, we could detect
Venus labeling in a subset of Nkx6.1 cells at 14 hpf
(Fig. 6a, a') while 3 hours later (17 hpf), Venus was
found in the vast majority of Nkx6.1+ cells (Fig. 6b, b').
Similarly, at the beginning of the formation of the ven-
tral bud (38 hpf ), only a subpopulation of Nkx6.1+ cells
present some Notch activity (Fig. 6c, c') while at 65 hpf,
the vast majority of Nkx6.1+ cells show Notch activity
with the exception of the EPD anlagen (Fig. 6d, d'),known to be Notch inactive [34]. At 4 days, virtually all
Nkx6.1+ cells are Notch-responsive in the IPDs (but the
EPDs are still devoid of Notch activity) (Fig. 6e, e').
In conclusion, these observations indicate that, in both
the dorsal and ventral buds, nkx6.1+ cells progressively
acquire Notch signaling activity, essential for maintain-
ing nkx6.1 expression.
nkx6.1 expression persists in ductal cells in the pancreas
of adult zebrafish
We then wanted to characterize nkx6.1 expression in the
pancreas of adult zebrafish. Immunodetection on paraf-
fin sections through the pancreas of Tg(nkx6.1:eGFP) fish
that were 6 to 9 months old revealed that nkx6.1:eGFP
expression persists in adult zebrafish (Fig. 7a). Compari-
son of endogenous Nkx6.1 protein and GFP shows that,
in the adult too, Tg(nkx6.1:eGFP) recapitulates the pat-
tern of Nkx6.1 expression (data not shown). nkx6.1:eGFP
expression is confined to the ducts and to isolated cells
scattered throughout the exocrine tissue and was not
detected in beta cells (Fig. 7a, a') or acinar cells. These
nkx6.1:eGFP+ cells dispersed within the exocrine pan-
creas exhibit long cellular extensions characteristic of
CACs (inset in Fig. 7a) [12]. In the adult zebrafish
pancreas, as in mammals, the CACs can also be identi-
fied by Notch signaling activity [12]. Thus, to confirm
the expression of nkx6.1 in CACs, we used the Notch
reporter line Tg(Tp1:VenusPest) [16], in which the desta-
bilized Venus fluorescent protein (VenusPest) highlights
cells harboring ongoing Notch activity, and which labels
the CACs, as expected (Fig. 7b and inset). All Venus+
cells in the pancreas were found exclusively in the ductal
system, and more particularly in the CACs and not
within the ductular structures (Additional file 6: Fig. S6).
Comparison of Venus with Nkx6.1 confirmed that
Nkx6.1 is indeed expressed in all Venus+ CACs (Fig. 7c, c').
In contrast, while ducts also display nkx6.1 expression as
revealed with either nkx6.1:eGFP (Fig. 7a, a') or with
the endogenous Nkx6.1 protein (Fig. 7d), they are
devoid of Notch ongoing activity (white arrows point-
ing at Venus– ducts in Fig. 7b, d; see also Fig. 8a and
Additional file 6: Fig. S6).
Adult centroacinar cells display progenitor capacity in
physiological conditions
We then asked whether CACs could generate other pan-
creatic cell types in adult zebrafish under physiological
conditions by using the double Tg(Tp1:VenusPest);
Tg(Tp1:H2BmCherry) in which the stable H2BmCherry
protein labels cells harboring ongoing Notch activity
(Venus+ mCherry+) and cells having previously experi-
enced Notch activity (Venus– mCherry+) [16]. This tool
has been previously exploited to characterize and follow
the fate of the Notch-responsive progenitors in the IPDs
Fig. 5 (See legend on next page.)
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Fig. 6 The pancreatic expression domain of Nkx6.1 includes the Notch-responsive cells. Immunodetection of endogenous Nkx6.1 (red) and Venus
(revealed with anti-GFP, green) in Tg(TP1:VenusPest) (a–c') or GFP in Tg(Tp1:eGFP) embryos (d–e') at the indicated stages. All views are ventral with
the anterior part to the left and represent either z-plane confocal images (b–c') or confocal projection images (a, a', d, d', e, e'). Scale bars = 40 μm.
EPD extra-pancreatic duct, IPD intra-pancreatic duct
(See figure on previous page.)
Fig. 5 ascl1b and nkx6.1 are regulated in an opposite way by the Notch signaling pathway. a–f WISH on wild-type (WT) embryos (a, c, e) or mind
bomb (mib-/-) mutants (b, d, f) with ascl1b (a, b) or nkx6.1 (c–f) probes. Brackets delimit the pancreatic domain. g, h Immunodetection of GFP and
endogenous Nkx6.1 in 5-dpf Tg(ascl1b:eGFP-creERT2) embryos treated from 3 to 5 dpf with DMSO (g) or with the Notch signaling inhibitor, LY411575 (h).
i–n WISH with ascl1b (i, j) or nkx6.1 (k, l) probes or immunodetection of endogenous Nkx6.1 (m, n) of double-transgenic Tg(hsp70:Gal4) x Tg(UAS:NICD)
embryos (j, l, n) or of control simple-transgenic embryos (i, k,m), both heat-shocked at 11 hpf for 20 min. Lateral views (a–f, k, l) or ventral views (g–j,m, n) of
embryos of the indicated stages with the anterior to the left. Scale bars = 40 μm
Ghaye et al. BMC Biology  (2015) 13:70 Page 11 of 24
Fig. 7 Expression of nkx6.1 persists in duct cells in the adult pancreas. a GFP and insulin (Ins, red) immunodetection on section through the pancreas of
adult Tg(nkx6.1:eGFP) zebrafish. White arrows point to pancreatic ducts and asterisks show cells (presumably centroacinar/ terminal end duct cells (CACs)
dispersed throughout the exocrine tissue). a' Close-up of the islet highlighted with Ins. b Venus (green) and Ins (red) immunodetection in Tg(Tp1:VenusPest)
showing the presence of Venus in CACs (asterisks) as previously reported [12], but not in duct cells within ductular structures (white arrow). Insets in (a) and
(b) show isolated CACs. c–d Immunodetection of Venus (green) and of endogenous Nkx6.1 (red) in Tg(Tp1:VenusPest) revealing co-labeling of both markers
in CACs (c, c') while Nkx6.1 alone, but not Venus, labels the ducts. The white arrow in (d) points to a duct and asterisks indicate CACs. Dotted
yellow lines delimit the duct. c' Same as (c) showing Nkx6.1 (red) and 4',6-diamidino-2-phenylindole (DAPI) only. i, islet
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H2BmCherry+ cells in adult fish to identify the pancre-
atic cell types derived from CACs. In about 30 % of all
H2BmCherry+ cells, Notch activity was switched off
(Venus–). Many of these cells, with weak H2BmCherry
labeling, were identified within small ducts (Fig. 8a–c),
which can be identified by the ductal marker 2F11
(Fig. 8b, c and Additional file 7: Fig. S7A-C for the
separated colors and additional example) [11, 22, 36] or
by Nkx6.1 (Additional file 7: Fig. S7D), and at the tip of
which reside CACs (intense H2BmCherry, asterisks in
Fig. 8c and Additional file 7: Fig. S7). Furthermore, low
levels of H2BmCherry were also identified in some
insulin-expressing cells (Fig. 8d, d'). About 4.9 ± 2.6 %
(n = 4) of the H2BmCherry+/Notch off (Venus–) display
Ins labeling. These findings show that mCherry+ terminal
end duct cells and insulin-expressing cells originate fromNotch positive CACs. Overall, this reveals that a subset of
the Nkx6.1+ ductal cells, the Notch-responsive CACs, can
generate ductal and endocrine cells.
To determine the capacity of CACs to replicate,
their proliferative status was analyzed using 5-ethynyl-
2′-deoxyuridine (EdU) labeling and proliferating cell
nuclear antigen (PCNA) immunodetection in Tg(Tp1:-
VenusPest) adult fish. One day after EdU injection, a small
fraction of CACs (5.8 ± 2.6 %, out of 600 counted CACs)
had incorporated EdU. All these EdU+ Venus+ cells also
express the proliferation marker PCNA (Fig. 8e, e'). In
contrast, 5 days post injection, Venus+ cells that still
display EdU labeling were no longer PCNA+ (Fig. 8f, f'),
but still harbor characteristics of CACs, suggesting
that they became post-mitotic CACs. The capacity of
CACs to replicate together with their ability to
undergo ductal and endocrine differentiation indicate
Fig. 8 (See legend on next page.)
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Fig. 8 In the adult pancreas, Notch-responsive CACs give rise to other ductal and endocrine cells and have the capacity to replicate. Immunodetection on
sections through the pancreas of adult Tg(Tp1:VenusPest); Tg(Tp1:H2BmCherry). a Comparison of Venus (green) and H2BmCherry (red) labeling showing a
small duct containing H2BmCherry+ cells that have lost Venus. b Comparison of H2BmCherry (red) with the ductal marker 2F11 (green) showing some
2F11+ cells within a small duct co-expressing the stable H2BmCherry marker (yellow arrow). c Weak H2BmCherry labeling near the extremity of a ductular
structure (terminal or intercalated duct) (yellow arrows); a CAC (intense H2BmCherry) at the tip of the terminal duct is indicated by an asterisk. d and d'
(close-up) Some H2BmCherry+ cells, devoid of Venus (Notch off) co-express the beta cell marker Ins (white) (yellow arrows). Sections acquired in the head
of the pancreas, at the level of the main endocrine islet. e–f' Detection of 5-ethynyl-2′-deoxyuridine (EdU) (red), Venus (green), and proliferating cell nuclear
antigen (PCNA) (white) in Tg(Tp1:VenusPest) adult fish injected with EdU. The pancreas was analyzed 20 hours (1 day post injection) (e, e') and 5 days (f, f')
after EdU injection
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stem cells in vivo.
nkx6.1-expressing ductal cells contribute to beta cell
regeneration in adult zebrafish
The capacity of CACs to differentiate into beta cell in
the normal adult zebrafish raises the question whether
similar plasticity exists for regeneration. To induce beta
cell regeneration, we used the Tg(ins:NTR-mCherry) line
[1] and treatment with metronidazole (MTZ). The
metronidazole is converted into a cytotoxic compound
by the nitroreductase enzyme (NTR), which thereby
triggers selective beta cell death by apoptosis [3]. In
adult zebrafish, the ablation of beta cells causes dramatic
hyperglycemia within 3 days rapidly followed by spontan-
eous normalization within 2 weeks and beta cell regener-
ation [2]. To analyze the ductal cells in the setting of beta
cell regeneration, Tg(nkx6.1:eGFP); Tg(ins:NTR-mCherry)
adult fish were treated with MTZ (day 1) and sacrificed at
different time points during regeneration to analyze GFP
and Ins on tissue sections at the level of the principal islet.
The blood glucose level was measured just before sacri-
fice. At 3 days post treatment (dpt), ablation was total
and effective as reported [2, 37]. MTZ-treated fish
displayed severe hyperglycemia as expected (>500 mg/
dl, n = 10 fish) while the glycemia of non-treated fish
was at normal values of 61 ± 19 mg/dl (n = 11). Immuno-
labeling at 3 dpt indicated total beta cell ablation as mani-
fested by the absence of insulin staining in the pancreas of
MTZ-treated Tg(nkx6.1:eGFP); Tg(ins:NTR-mCherry) fish
(Fig. 9a, b). At 9 dpt, the first new beta cells have started
to reappear (Fig. 9c). Glycemia was still above normal
values but nonetheless had decreased (145 ± 31 mg/dl,
n = 2). The principal islet in the treated fish still
showed very weak insulin expression but a few new
beta cells (about 5 % of the islet cells, compared to
40–70 % in control fish) can be detected in the princi-
pal islet as well as throughout the exocrine tissue as
isolated cells or as small clusters of Ins-expressing
cells next to CACs and ductal cells marked by GFP
(Fig. 9c, yellow arrows). The presence of insulin-expressing
cells at 9 dpt is indicative of beta cell regeneration. Interest-
ingly, some of the regenerating insulin+ cells displayed
weak GFP staining (7.9 ± 3.2 % of the Ins+ cells, 452counted cells, n = 2 fish) (Fig. 9f). These cells were found
next to strongly GFP-labeled ductal nkx6.1:eGFP cells.
GFP+ Ins+ cells were also detected at 21 dpt (11.1 ± 4.3 %
of the Ins+ cells, 940 counted cells, n = 2 fish) (Fig. 9g). At
this stage, a large number of beta cells have recovered
(about 30–50 % of islet cells, Fig. 9d) [2, 37] and glycemia
was normalized (57 ± 9 mg/dl). In contrast, insulin+ cells
never harbor GFP labeling in non-treated fish (Fig. 9e).
Thus, by using the same approach of short-term tracing of
nkx6.1:eGFP+ cells as in embryos, this finding strongly
suggests that ductal nkx6.1:eGFP+ cells contribute to
regenerated beta cells.
Next we assessed proliferation in Tg(nkx6.1:eGFP);
Tg(ins:NTR-mCherry) in response to beta cell ablation.
Three days post treatment, nkx6.1:eGFP ductal cells
showed increased proliferation as illustrated with PCNA
(Fig. 9h, i). This was observed not only within ductal
structures as previously described ([2] and not shown)
but also for CACs. These observations suggest that
ductal cells with pancreatic progenitor properties
activate proliferation prior to differentiation into beta
cells during regeneration.
Transcriptomic analysis of adult nkx6.1+ pancreatic ductal
cells
To get a comprehensive characterization of pancreatic
nkx6.1+ ductal cells in adult zebrafish, we determined
their transcriptome landscape. Ductal GFP+ cells were
isolated from dissected pancreases of adult Tg(nkx6.1:eGFP)
fish (with ~95 % purity) and used in RNA-seq experiments.
The expression of 15,888 genes could be detected in the
ductal transcriptome (complete data available at [38]), in
which many genes already known to be expressed in
pancreatic ducts in either zebrafish or mammals were
found at high expression level, such as sox9b, hnf1ba,
onecut1/hnf6, cftr, cdh17, ca2, and ctgfa in addition to
nkx6.1 (Fig. 10). We also detected expression of fgfr4
and sdc4, recently proposed as novel ductal markers in
the murine embryonic pancreas [39]. In contrast to
these ductal genes, the acinar markers ptf1a and rbpjl,
the pan-endocrine markers pax6b and isl1, and the
lineage specific genes mnx1 and arx were either not
detected or detected at extremely low levels in the
nkx6.1:eGFP+ ductal cells transcriptome (Fig. 10),
Fig. 9 (See legend on next page.)
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Fig. 9 nkx6.1:eGFP+ cells proliferate and differentiate into new insulin-expressing cells after beta cell specific ablation. GFP (green) and Ins (white)
labeling in the pancreas of Tg(nkx6.1:eGFP); Tg(ins:NTR-mCherry) adult fish. a, b Non-treated fish (CTL, a) show intense Ins staining in beta cells,
while Ins+ cells are not detected 3 dpt with MTZ, indicating efficient ablation (b). Note that debris of one beta cell (Ins+) is observed in the islet.
c At 9 dpt, Ins-expressing cells start to be detected in the principal islet and in extra-insular locations close to ductal GFP+ cells (yellow arrows). d
At 21 dpt, islets show intense Ins staining consistent with beta cell recovery. e–g (and separate channels) While GFP is never detected in beta
cells of control fish (e), some regenerating Ins+ cells display weak GFP labeling at both stages of regeneration analyzed, i.e. at 9 dpt (f) and 21
dpt (g). h, i (and separate channels) Beta cell ablation triggers proliferation of CACs as shown at 3 dpt (h) compared to CTL (i) (asterisks). i islet
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cell sorting (FACS) cell preparations. In contrast to
mouse or human adults in which the embryonic
pancreatic progenitor marker Pdx1 is not expressed in
the pancreatic ducts in normal condition, nkx6.1:eGFP+
duct cells of healthy zebrafish display a robust expres-
sion of pdx1. Comparison of the duct transcriptome
with those of pancreatic acinar and endocrine cells
(manuscript in preparation) highlighted 3,684 genes
with preferential expression in duct cells. Among
them, 293 duct-specific genes were identified with
strong enrichment (≥16-fold) and low expression in
the other pancreatic cells (Additional file 8: Table S1),
in which we find sox9b, onecut1/hnf6, cdh17, ctgfa, and
nkx6.1, corroborating their status as duct-specific
markers. Various components of the Notch signaling
pathway could also be identified, namely notch2, and
different Hairy and enhancer of split-related genes
(her6, her9, and her15.1), confirming that a subpopula-
tion of nkx6.1+ cells (the CACs) experiences NotchFig. 10 Expression of known pancreatic markers in the transcriptome of ad
counts. High expression of known ductal genes (orange box) is detected w
abundance, with the exception of pdx1 and ascl1b (see text)activity. In addition to genes involved in the Notch
signaling cascade, our analyses also identified novel
duct-specific markers such as id2a, encoding for a
HLH transcription factor, which we also detected co-
expressed with sox9b by WISH in 3-dpf larvae (Additional
file 9: Fig. S8), and several components of the Wnt
pathways such as the Wnt and SFRP ligands sfrp5,
sfrp3/frzb, and wnt7bb (Additional file 8: Table S1).
At a lower expression level, we could also detect the
Wnt receptor fzd7a, which was the only Wnt receptor
significantly expressed in the adult pancreas (565 ± 106
normalized counts with 68-fold enrichment in the ducts).
These observations suggest that Wnt signaling may play
an important role in adult ducts.
Strikingly, the only endocrine transcription factor that
displayed substantial expression (>1000 counts) and
enrichment in the ductal transcriptome was the pro-
endocrine gene ascl1b (Fig. 10). As ascl1b specifically
marks the endocrine precursors during pancreas devel-
opment, these data support our observation that, withinult nkx6.1:eGFP cells. Expression values are expressed as normalized
hile acinar (green box) and endocrine (red box) markers display low
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pro-endocrine differentiation program in normal adult
zebrafish.
Discussion
In this study, we determined during development the
fate of two pancreatic cell populations marked by nkx6.1
and ascl1b and found that nkx6.1+ cells are bona fide
multipotent pancreatic progenitors while ascl1b+ cells
represent committed endocrine precursors. We found
also that nkx6.1 is maintained in adult zebrafish in ducts
and CAC/terminal end duct cells, which we show still
have the potential to give rise to endocrine cells in
normal (non-diabetic) animals. The progenitor potency
of adult nkx6.1+ cells is also reflected in their transcrip-
tome through the expression of several pancreatic
progenitor markers and by their capacity to generate
new beta cells after beta cell ablation.
Although ascl1b marks the endocrine precursor cells,
as opposed to nkx6.1, which is the first multipotent pan-
creatic progenitor marker known to date, it is surprising
to note that this transcription factor begins to be
expressed in the prospective pancreatic region at 10 hpf
[15], i.e. more than 1 hour before the appearance of
nkx6.1 (11.5 hpf) [18]. Pdx1, known in the mouse to be
also expressed in the multipotent pancreatic progenitors,
appears even later (14 hpf [6]). This brings the interest-
ing concept that the first cells in the pancreatic anlagen
acquire an endocrine identity before acquiring a pancre-
atic identity, suggesting that the mechanisms controlling
pancreatic and endocrine identity are not necessary
linked and can act in parallel. This situation seems to be
restricted to the dorsal bud as, later, nkx6.1 is first
expressed during the formation of the ventral bud and
ascl1b is then detected in endocrine committed cells.
This peculiar situation could be related to the different
lineage potential of the dorsal versus ventral bud cells.
Indeed the dorsal bud gives rise exclusively to endocrine
cells while the ventral bud is able to give rise to all
pancreatic cell types [4, 40].
After a transient overlapping expression in the dor-
sal pancreatic anlagen, nkx6.1- and ascl1b-expressing
domains segregate progressively. Cross-repressive
interactions between lineage-determining transcrip-
tion factors have been proposed as a molecular mech-
anism for establishing lineage allocation in several
tissues [41–43]. We show that such a mechanism does
not occur here, as we could not observe any cross-
repression between nkx6.1 and ascl1b in the dorsal
bud when analyzing both mutants. The segregation
can instead be explained by the opposite effects of the
Notch signaling pathway on nkx6.1 and ascl1b expres-
sion. By loss- and gain-of-function experiments, we
definitely prove that ascl1b is repressed, while nkx6.1is maintained, by Notch signaling in both the dorsal
and ventral buds. The importance of Notch signaling
in regulating nkx6.1 expression has been also shown in
mice where disruption of Notch signaling results in
the loss of the pro-trunk determinant Nkx6.1 and the
acquisition of pro-acinar identity [44]. Direct binding
of RBPJ-K to the Nkx6.1 promoter supports a direct
role of Notch signaling in the expression of Nkx6.1. In
contrast, the initiation of nkx6.1 expression is inde-
pendent of Notch signaling in both zebrafish pancre-
atic buds. This is in accordance with our findings that
Nkx6.1+ cells progressively become Notch-responsive
PNCs being found only in a subpopulation of the
Nkx6.1+ cells at the beginning of the formation of
both the dorsal and ventral buds. This could explain
why the PNCs, found in a subdomain of the ventral
bud at an early stage, can differentiate only into ductal
and endocrine cells, while nkx6.1-expressing cells give
rise to all pancreatic cell types. As nkx6.1 and ptf1a
are initially co-expressed in the ventral bud primordium
([20] and our unpublished data), we can hypothesize that
the nkx6.1+/ptf1a+/Notch on cells give rise to the ductal
and late endocrine cells while the nkx6.1+/ptf1a+/Notch
off cells will give rise to the acinar cells. This model
appears to contradict the data of Wang et al. [7] showing
that the ventral bud primordium consists of two non-
overlapping cell populations: a ptf1-expressing domain
and a Notch-responsive progenitor core. It is possible that
this discrepancy is due to the tools used to label the
Notch-responsive cells: in our study, we used the
Tp1bglob:VenusPest transgenic line allowing the detection
of cells with current Notch activity, while Wang and
collaborators used the Tp1bglob:hgmb1-mCherry line,
which could show a delay in mCherry detection.
In adult zebrafish, nkx6.1 expression persists in the
pancreas where it is specifically restricted to the ducts.
This situation is different in the mouse as Nkx6.1
persists in beta cells but not in adult ducts. In zebrafish,
it is nkx6.2, an nkx6.1 homolog with functional equiva-
lence [18, 45], which is expressed specifically in beta
cells [18], suggesting that the Nkx6 function in beta cells
is fulfilled by Nkx6.2 in zebrafish. Persistence of nkx6.1
expression in the zebrafish ducts is also associated with
persistence of another pancreatic progenitor marker,
pdx1, whose expression is also restricted to beta cells in
mammals. Combined with other hallmarks of embryonic
pancreatic progenitors such as sox9b, hnf1ba, and Notch
signaling components, the expression of genes nkx6.1
and pdx1 suggests that at least some ductal cells behave
as pancreatic progenitors in adult zebrafish. Moreover,
detection of the endocrine precursor marker ascl1b in
the adult nkx6.1:eGFP+ ductal cell transcriptome is
consistent with some ductal cells initiating an endocrine
differentiation program and transiently expressing ascl1b,
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of ductal cells is fully revealed in the setting of beta cell
regeneration where nkx6.1:eGFP+ cells show increased
proliferation as well as the ability to differentiate into new
beta cells. The adult pancreatic progenitors contributing
to beta cell regeneration could be the CACs, as supported
by our observation that they are able to replicate and to
generate other ductal cells as well as endocrine beta cells.
On the other hand, we cannot exclude the possibility that
other ductal cells also contribute to regeneration based on
Tg(nkx6.1:eGFP), which labels more broadly the ducts.
Nevertheless, although the tool we used here to monitor
lineage tracing presents some limitations (based on the
persistence of GFP in assessing the short-term lineage
tracing of nkx6.1-expressing cells), during the revision of
our manuscript, a study by Delaspre et al. [37] established
through CRE-based genetic labeling that Notch-responsive
cells give rise to regenerated beta cells in adult zebrafish.
Our data are in full accordance with their findings, and
support the conclusion that ductal cells, possibly CACs,
possess regenerative capacity. To determine whether
CACs only or other ductal cells contribute to beta cell
regeneration will require other genetic lineage tracings
with markers expressed only in ductular structures and
not in CACs.
In contrast to mammals, the adult zebrafish has the
remarkable capacity to regenerate its beta cells rapidly
and spontaneously following their selective destruc-
tion [2]. Our findings showing that ductal cells, such
as CACs, behave as pancreatic progenitors/stem cells
in normal (non-diabetic) adult animals and during re-
generation strongly suggest that they could also con-
stitute a source of regenerated beta cells in diabetic
mammalian models. In the mouse, adult murine CACs
display endocrine and exocrine progenitor potential
in vitro with self-renewing ability [46], but evidences
of their potential in vivo as progenitors of endocrine
cells are missing. Indeed, CRE-based cell tracing of
Hes1+ terminal duct cells/CACs in adult mice failed
to show any islet progenitor capacity while these cells
seemed to contribute to the ductal tree [47]. One ex-
planation for this difference would be that while zeb-
rafish CACs present pancreatic progenitor activity,
mammalian CACs have retained a very limited cap-
acity in vivo, which could not be evidenced in the
mouse model of beta cell regeneration used. Another
explanation would be that CACs form a heteroge-
neous cell population. This latter hypothesis could be
verified by the analysis of the expression of different
ductal markers identified in our transcriptome, which
could help determine the existence of different ductal
cell subpopulations.
A perspective of our work would be to examine thor-
oughly in zebrafish ductal cells in physiological conditionsand during beta regeneration to identify mechanisms that
could then be harnessed to promote beta cell regeneration
in mammals. A first clue is provided by the fact that
Nkx6.1 and Pdx1 are normally not expressed in mamma-
lian duct cells, in contrast to zebrafish. It is therefore
tempting to hypothesize that inducing the expression of
these two factors in the pancreatic ducts in the adult
mouse or human could enhance their progenitor poten-
tial. Consistent with this hypothesis, driving ectopic Pdx1
expression is already harnessed for transdifferentiating
different cells into beta cells in vivo (liver cells, pancreatic
acinar cells, …) [48–51] and for transdifferentiating
pancreatic duct cells into beta cells in vitro [52]. Interest-
ingly, the ability of Pdx1 to reprogram liver cells into beta
cells is substantially increased by the combined action of
Nkx6.1 [53], which potentiates induction of the early
pancreatic master genes Neurog3 and Isl1.
In the zebrafish larvae, two sources have been
described for the regeneration of beta cells: progenitor
cells in the developing ducts [35] and alpha cells [54].
From our data in adults, we cannot rule out the contri-
bution by other cell types than ductal cells. Indeed, in
addition to increased proliferation of ductal cells, some
islet cells show also increased proliferation after beta cell
destruction ([2] and our data not shown) suggesting the
involvement of other pancreatic, and possibly endocrine,
cell types in regeneration. These possibilities remain to
be validated in the adult zebrafish.
Our transcriptomic characterization of nkx6.1+ cells in
normal non-regenerating adult zebrafish identified many
of the ductal markers known throughout species, show-
ing that many of these genes and their expression are
conserved between zebrafish and mammals, as for
example, different markers of Notch signaling [55–57],
and sdc4 and fgfr4. These latter two genes have been
previously proposed as ductal markers in the mouse
embryo [39]. Additional markers were also identified
here, notably id2a. Id2 has been shown to be expressed
in ductal epithelial cells of IFNγNOD mice, a model of a
regenerating pancreas harboring hyperplasic ducts, and
to be involved in their expansion [58]. We demonstrate
here its expression in ducts in larvae and in healthy
adult pancreas, which may correlate with a role in devel-
opment and in ductal constitutive homeostasis. Our
findings also reveal that, besides the Notch pathway,
ductal cells specifically express various components of
Wnt signaling pathways. The expression of the fzd7a
receptor, of two secreted Wnt antagonists, sfrp5 and
frzb/sfrp3, and of the agonist wnt7bb suggests a complex
control of the activity of the Wnt pathway(s) in adult
pancreatic ducts. Whether and how these different factors
orchestrate pancreatic duct development, homeostasis,
and function remains to be determined. Numerous cross-
talks between the Notch and the Wnt/beta-catenin
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and disease, notably by regulating the balance of stem cells
and differentiated cells (reviewed in [59]). During pancreas
development, beta-catenin controls the patterning of mul-
tipotent versus bipotent embryonic pancreatic progenitors
in the mouse, in part, by inhibiting Notch signaling [60].
Our findings raise the question whether similar interac-
tions shape the fate decision of progenitors/stem cells in
the adult pancreas.
Conclusions
We have developed transgenic tools enabling the
characterization of nkx6.1+ and ascl1b+ progenitor cell
populations and showed that, in the zebrafish embryo,
nkx6.1+ cells are multipotent pancreatic progenitors,
while ascl1b+ cells represent committed endocrine pre-
cursors. In adult zebrafish, nkx6.1 expression persists
exclusively in the ductal tree, notably in CACs. Tran-
scriptomic profiling of adult nkx6.1+ ductal cells reveals
hallmarks of embryonic pancreatic progenitors and identi-
fies novel ductal markers. Our data also strongly suggest
that adult zebrafish ductal cells, possibly CACs, possess
regenerative capacity. Further characterization of ductal
cells in this animal model should bring new insight into
regeneration in mammals and open up new perspectives
for anti-diabetic therapies.
Methods
Zebrafish maintenance, mutant and transgenic lines, and
LY411575 treatment
Zebrafish (Danio rerio) were raised and cared for ac-
cording to standard protocols [61]. All animal work has
been conducted according to national guidelines and all
animal experiments described herein were approved by
the ethical committee of the University of Liège
(protocol numbers 371, 1285, and 1662). Wild-type
embryos from the AB strain were used and staged ac-
cording to Kimmel [62]. Homozygous mind bomb mu-
tants were obtained by mating heterozygous fish for
the (mibta52b) allele [63]. The following transgenic
lines were used: Tg(hsp70l:Gal4)1.5kca4 abbreviated
Tg(hsp:Gal4) and Tg(UAS:myc-Notch1a-intra)kca3 ab-
breviated Tg(UAS:NICD) [33], Tg(Tp1bglob:eGFP)um14
abbreviated Tg(Tp1:eGFP) [12], Tg(TP1bglob:Venus-
Pest)S940 abbreviated Tg(TP1:VenusPest) [16], Tg
(Tp1bglob:H2BmCherry)S939 abbreviated Tg(Tp1:H2BmCherry)
[16], Tg(ubi:loxP-EGFP-loxP-mCherry) abbreviated ubi:-
Switch [28], Tg(ubi:loxP-AmCyan-loxP-ZsYellow) abbre-
viated ubi:CSY [27], Tg(ins:NTR-mCherry) [1], and
Tg(nkx6.1:eGFP); Tg(ins:NTR-mCherry).
The LY411575 treatment was performed by incubat-
ing the embryos during the indicated period with a 10-μm
LY411575 solution (Medchemexpress), replaced every
day.Generation of BAC transgenic lines
The polymerase chain reaction (PCR) primers used to
generate the constructs are listed in Additional file 10:
Table S2. The BAC:nkx6.1 (Imagenes, DKEY-173 K2)
DNA was introduced by electroporation into SW102 E.
coli (derived from DY380) [64]. These bacteria contain
the lambda prophage recombineering system and a
galactose operon where the galactokinase gene (galK)
has been deleted. The eGFP gene was inserted into exon
1 of nkx6.1, replacing the beginning of the nkx6.1 open
reading frame (amino acids (aa) 1 to 149) using a two-
step positive and negative galk selection [25, 64, 65].
During the first step, the cassette containing the galk
gene was amplified by PCR with the pair of primers
O180F and O253R, containing at the 5′ end 50 bases
identical to the nkx6.1 sequence to allow homologous
recombination and electroporated into the bacteria
SW102 containing BAC:nkx6.1. Only recombinant bac-
teria are able to grow on minimal medium containing
galactose as carbon source. During the second step, the
galK gene was replaced by the eGFP gene. The eGFP
cassette was amplified by PCR with the primers O186F
and O256R containing at the 5′ end the same 50 bases
identical to the nkx6.1 sequence to allow homologous
recombination and the eGFP sequences to anneal to the
eGFP cassette. After electroporation, the bacteria were
plated on minimal medium containing two-deoxy-D-gal-
actose (DOG), a galactose analogue that after phos-
phorylation by GalK, becomes toxic. Only bacteria that
have lost the galk gene survived on DOG-containing
medium. To facilitate the insertion of the BAC in the gen-
ome of zebrafish, the iTol2 cassette was also inserted
into the backbone of BAC:nkx6.1-eGFP [24, 25, 65].
The iTol2 cassette was amplified by PCR with the
pair of primers O215F and O216R. The final con-
struct (BAC:nkx6.1-eGFP) was purified with Nucleo-
bond® BAC100 (Macherey-Nagel) and injected into the
cytoplasm of one-cell-stage zebrafish embryos together
with the mRNA for the transposase. The embryos
and larvae were screened for GFP expression and the
fluorescent injected fish were raised to adulthood and
the offspring were screened for fluorescence. The trans-
genic line obtained was abbreviated to Tg(nkx6.1:eGFP) in
the article.
To generate the (ascl1b:eGFP-2A-creERT2) transgenic
line, we used BAC:ascl1b (Imagenes, DKEY-265 N18)
spanning from 61 kb upstream and 89 kb downstream
of the ascl1b gene. The GFP-2A-creERT2 cassette was
inserted into exon 1 of ascl1b, replacing the beginning
of the ascl1b open reading frame (aa 1 to 163) using the
same two-step positive and negative galk selection as
described above. For the first step, the cassette contain-
ing the galk gene was obtained by PCR using the
primers O275F and O276R and for the second step, the
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O277F and O278R.
4OHT treatment for creERT2 induction
4-Hydroxytamoxifen (4OHT, Sigma H7904) was dissolved
in DMSO as a stock solution of 10 mM and kept in
single-use aliquots in the dark at –70 °C. A working
concentration of 10 μM 4OHT was demonstrated to
lead optimally to Cre-mediated recombination without
causing deleterious development defects. Embryos were
treated five times from 11 to 15 hpf in E3 containing 10
μM 4OHT and kept in the dark at 28 °C. After the
treatments, the embryos were washed in fresh E3 and
fixed at 48 hpf or 72 hpf.
CRISPR/cas9 genome mutagenesis
The nkx6.1 and ascl1b mutant lines were generated by
CRISPR/Cas9 technology essentially as described previ-
ously [31, 66]. The targeted sites were selected using the
ZiFiT software package [67] in the first exon of nkx6.1
(CCAAACCCCTGACAGAGCTTC) before the homeo-
domain coding region and in the first exon of ascl1b
(GGAGACGCTGCGCTCCGCCGTGG) corresponding
to the helix-loop-helix coding domain. The selected
oligonucleotides were inserted into the plasmid DR274
(Addgene) and the gRNA (guide RNA) was synthesized
by in vitro transcription using T7 RNA polymerase.
Fertilized zebrafish eggs were injected with about 1 nl of
a solution containing 50 ng of gRNA and 300 ng of nls-
zCas9-nls mRNA obtained by transcription of the
plasmid pT3TS-nCas9n (Addgene). The efficiency of
mutagenesis was verified by genotyping using Heterodu-
plex Migration Assays [68] after amplification of tar-
geted genomic sequences. Injected embryos were raised
until adulthood and crossed with wild-type fish to gener-
ate heterozygote mutant F1 fish. Fish harboring frame-
shift mutations were kept and used to raise F2 mutant
lines, i.e. the ascl1bulg-M2C and nkx6.1ulg-M5 lines carry-
ing, respectively, 11 and seven nucleotide deletions.
Whole mount in situ hybridization, whole mount
immunohistochemistry, and immunohistochemistry on
paraffin sections
Double fluorescent and visible WISH were performed as
previously described [69, 70] with the following probes:
ascl1b [15, 71], nkx6.1 [18, 72], somatostatin 2 (sst2)
[73], and try [6].
Immunohistochemistry (IHC) on whole-mount embryos
was performed as described [15]. For IHC on paraffin sec-
tions with adult tissues, adult fish between 6 and 9 months
old were fixed in 4 % PFA (paraformaldehyde) overnight
at 4° after euthanasia and opening of the abdominal skin.
The digestive tract was then dissected and embedded in
paraffin following standard procedures. Then, 5-μmsections were collected through the head of the pancreas
at the level of the main pancreatic islet. Immunodetection
was performed after standard antigen retrieval.
The antibodies used were: polyclonal rabbit anti-
mCherry/dsRed (Living Colors DsRed Polyclonal Antibody,
Clontech) 1:500, polyclonal rabbit anti-ZsYellow (Living
Colors anti-RCFP polyclonal pan from Clontech) 1:300,
chicken anti-GFP (Aves lab) 1:1000, mouse monoclonal
anti-Nkx6.1 (clone F55A10) 1:20, mouse monoclonal
anti-Isl1 (Hybridoma bank) 1:50, guinea pig anti-insulin
(Dako) 1:500, mouse anti-glucagon (Sigma) 1:300, poly-
clonal rabbit anti-somatostatin (MP Biomedicals) 1:300,
mouse anti-PCNA (Sigma) 1:1000, mouse 2F11 mAb
(Abcam) 1:1000, and Alexa Fluor secondary antibodies
(Invitrogen). Venus was detected with anti-GFP. Finally,
4',6-diamidino-2-phenylindole (DAPI) was used as
nuclear staining.
Images were acquired with a Leica SP2 or SP5 con-
focal microscope and processed with Imaris 7.2.3 and
Photoshop CS5. To count the Tp1:H2BmCherry+ cells
expressing insulin, the total number of pancreatic
mCherry+/Venus– and mCherry+/Ins+ cells was calcu-
lated for six sections every 15 μm for four fish.
EdU injection and detection in adult zebrafish
A 12.5-mM EdU solution in DPBS (Dulbecco's Phosphate
Buffer Saline) containing 0.25 % DMSO was injected in-
traperitoneally in 6–9-month-old fish at 100 μg/g body
weight after anesthesia in tricaine methane sulfonate. Fish
were then sacrificed and fixed in 4 % PFA. EdU (Click-iT®
Labeling Technologies, Life Technologies) incorporation
was detected on paraffin sections with Alexa Fluor555
before proceeding to IHC detection.
To count EdU+ cells, the total number of pancreatic
Venus+ CAC and Venus+/EdU+ cells was calculated in
three to six sections every 15 μm for four fish.
Induction of beta cell ablation in adult zebrafish
Adult Tg(nkx6.1:eGFP); Tg(ins:NTR-mCherry) zebrafish
between 6 and 9 months old were treated in fish water
containing 10 mM MTZ (three to four fish per 500 ml,
Sigma 3761) for 20 hours at 28 °C. Then the water was
replaced twice before re-integration into the system.
Fish were anesthetized with tricaine and their glycemia
was measured using the Accu-Chek Aviva glucometer sys-
tem (Roche Diagnostics) with blood collected at the level of
the tail. To minimize variations, the fish were fasted for 24
hours before measurement. After decapitation, the whole
fish were fixed in 4 % PFA overnight at 4 °C. The digestive
tract was then dissected prior to paraffin embedding.
FACS purification of ductal cells
The pancreas of three to five Tg(nkx6.1:eGFP) adult
fish (6–9 months old) were dissected and collected
Ghaye et al. BMC Biology  (2015) 13:70 Page 21 of 24in HBSS with calcium. Dissociation was performed in HBSS
(Hank's Balanced Salt Solution) with Ca2+/Mg2+ supple-
mented with 1 mg/ml collagenase IV (Life Technologies
17104-019) and collagenase P (Roche 1121386501) and 1.5
mg/ml dispase II (Life Technologies 17105-041) for 20 min
at 30 °C. After several washes in HBSS without Ca2+/Mg2+,
a single-cell suspension was obtained by Tryple Select
1× incubation for 10 min. Dissociation was stopped by
HBSS without Ca2+/Mg2+ containing 1 % BSA (bovine
serum albumin) and 2 mM EDTA (ethylenediaminetet-
raacetic acid). GFP+ cells were isolated on FACS Aria II
under purity mode and the purity of the sorted cells
was confirmed for a small fraction with an epifluores-
cence microscope (~95 %). Cells were immediately
lyzed in 3.5 μl of reaction buffer (SMARTer Ultra Low
RNA kit for Illumina sequencing, Clontech) and stored
at –80 °C. Three independent replicates were generated
from 6–9-month-old fish.
cDNA synthesis and library preparation
cDNA synthesis was performed using the SMARTer
Ultra Low RNA kit for Illumina sequencing (Clontech)
according to the manufacturer’s recommendations. Then
3000–5000 sorted GFP+ cells were directly lyzed in 3.5
μl of reaction buffer and immediately frozen at –80 °C.
cDNAs were synthesized, purified with Ampure XP
beads and then amplified with 13 PCR cycles with
Advantage 2 Polymerase Mix (50×, Clontech). The PCR
products were purified on SPRI AMPure XP beads
(Beckman Coulter), and the size distribution was checked
on a high-sensitivity DNA chip (Agilent Bioanalyzer).
cDNA libraries were prepared with TruSeq Nano DNA kit
or Nextera XT DNA (Illumina). For TruSeq Nano
libraries, 20–30 ng cDNA was sheared by sonication
(parameters adjusted to obtain fragments from 350 to
450 bp). For Nextera libraries, 1 ng was fragmented by
tagmentation. Then cDNA libraries were prepared
according to the manufacturer’s recommendations.
Samples were sequenced on an Illumina HiSeq 2000 at
an average of 72.3 million 100-bp paired-end reads.
RNA-seq data have been deposited in the European
Nucleotide Archive from EMBL-EBI [38].
Data analysis of the duct transcriptome
Before mapping, the first 30 bases of each read were
trimmed to remove the adapters incorporated by the cDNA
synthesis process. Trimmed reads were mapped to the zebra-
fish genome (Zv9, Ensembl genes version 75, ensembl.org)
using the Tophat v.2.0.9 software [74]. For the three repli-
cates, the total number of reads for Duct 1 was 40,336,250
(79.9 % mapped), for Duct 2 was 86,308,531 (82.5 %
mapped), and for Duct 3 was 91,980,011 (67.6 % mapped).
HT-Seq count was used to estimate the expression
level by counting how many reads align to each gene ofthe annotation (gene set, Ensembl.org) [75]. The expres-
sion of 15,888 genes was detected with at least one read
in all three replicates.
To describe the set of genes enriched or preferentially
expressed in ductal tissue, the ductal transcriptome was
compared with acinar and endocrine transcriptomes
prepared following the same methodology (composed of
alpha, beta, and delta cells, not shown here, manuscript
in preparation). The R package EBSeq was used to call
differential expressed genes [76]. Ductal genes were
identified based on their posterior probability (adjusted
by false discovery rate) of being differentially expressed
from the other two cell types. It was found that 3,684
genes were preferentially expressed in the duct transcrip-
tome. Stricter thresholds were applied to identify genes
with highly specific ductal expression (see “Results”).Additional files
Additional file 1: Figure S1. The bacterial artificial chromosome (BAC)
reporter line Tg(nkx6.1:eGFP) mirrors the expression of the endogenous
nkx6.1 gene. A Schematic representation of the −55 to +95 kb
nkx6.1:eGFP BAC transgene. This BAC includes sequence blocks that are
highly conserved amongst vertebrates (black boxes) located from 11 to
77 kb downstream of the nkx6.1 gene. By BAC recombineering using galK
selection, the eGFP cassette (green box) was introduced into exon 1,
replacing the beginning of the nkx6.1 open reading frame (aa 1 to 149).
B Epifluorescence microscopy images of the immunodetection of
endogenous Nkx6.1 (red) and GFP (green) in Tg(nkx6.1:eGFP) embryos.
Lateral views of 48 hpf embryos with the anterior part to the left. C
Confocal projection images of whole mount fluorescent in situ
hybridization on a Tg(nkx6.1:eGFP) embryo showing that the gfp
transcripts are not expressed in the insulin+ cells at 20 hpf. D Confocal
projection images of whole mount fluorescent in situ hybridization on a
Tg(nkx6.1:eGFP) embryo showing that the gfp transcripts are not
expressed in the isl1+ cells at 30 hpf. Scale bar = 15 μm. P pancreas.
(PNG 2609 kb)
Additional file 2: Figure S2. The bacterial artificial chromosome (BAC)
reporter line Tg (ascl1b:eGFP-creERT2) mirrors the expression of the
endogenous ascl1b gene. A Schematic representation of the −61 to +89
kb ascl1b:eGFP-2A-creERT2 BAC transgene. By BAC recombineering using
galK selection, the eGFP-2A-creERT2 cassette is introduced into exon 1,
replacing the beginning of the ascl1b open reading frame (aa 1 to 163).
B Epifluorescence microscopy images of the immunodetection of GFP in
17-hpf Tg(ascl1b:eGFP-creERT2) embryos. C, D Visible WISH showing expression
of endogenous ascl1b in a wild-type (WT) embryo (C) and of GFP in
Tg(ascl1b:eGFP-creERT2) embryos (D) at 15 hpf. Lateral views with the
anterior part to the left. P pancreas. (PNG 1068 kb)
Additional file 3: Figure S3. nkx6.1 expression is not repressed by Ascl1b.
A Schematic representation of wild-type (WT) and mutant Ascl1bulg-M2C
proteins. The basic domain (b) (+70/+78) is represented by a blue box and the
helix loop helix (HLH) domain (+79/+123) by a green box. The coding region
of the mutant Ascl1bulg-M2C protein contains an 11-bp deletion after the aa
107 codon, leading to a frameshift and the production of an aberrant region
of 48 aa instead of the second helix, known to be essential for the function of
the bHLH proteins. A' Table showing part of the nucleotide and protein
sequence of the ascl1b gene and of the mutated form in the Ascl1bulg-M2C
mutant. B, C WISH showing the drastic reduction of somatostatin expression
in the ascl1b-/- mutant compared to the WT embryo at 30 hpf. This phenotype
is identical to the one of embryos injected with a translation-blocking
morpholino, targeting the translation start site of ascl1b mRNA [15, 77, 78],
suggesting that the mutant Ascl1bulg-M2C is effectively a null mutant. D, E
Confocal projection images of Nkx6.1 immunodetection showing equivalent
Ghaye et al. BMC Biology  (2015) 13:70 Page 22 of 24number of nkx6.1+ cells in WT and ascl1b-/- mutants at 16 hpf. All views are
ventral with the anterior part to the left. Scale bars = 40 μm. (PNG 1321 kb)
Additional file 4: Figure S4. ascl1b expression is not repressed by
Nkx6.1. A Schematic representation of wild-type (WT) and mutant
Nkx6.1ulg-M5 proteins with the yellow box representing the homeodomain
and the red box representing the NK domain. The coding region of the
mutant Nkx6.1ulg-M5 protein contains a 7-bp deletion after the aa 141
codon, leading to the apparition of a STOP codon just after the deletion.
The black line represents the region of the protein recognized by the
Nkx6.1 antibody. A' Table showing part of the nucleotide and protein
sequence of the nkx6.1 gene and of the mutated form in the Nkx6.1ulg-M5
mutant. B, C Nkx6.1 immunodetection showing the loss of the full-length
Nkx6.1 protein in the nkx6.1-/- mutant. D, E Glucagon immunodetection
showing a drastic reduction of the number of glucagon-expressing cells
in the nkx6.1-/- mutant compared to the WT embryo at 30 hpf. This
phenotype is the same as the one of embryos injected with the MO1
translation-blocking morpholino, targeting the translation start site of
nkx6.1 mRNA [18], shown to prevent nkx6.1 expression efficiently in the
neural tube [72]. This strongly suggests that the mutant Nkx6.1ulg-M5 is a
null mutant. F, G Confocal projection images of fluorescent WISH showing
equivalent number of ascl1b+ cells in WT and nkx6.1-/- mutants at
15 hpf. All views are ventral with the anterior part to the left. Scale
bars = 40 μM. (PNG 1527 kb)
Additional file 5: Figure S5. The initiation of nkx6.1 expression is
independent of Notch signaling. A–D Fluorescent WISH showing a
drastic increase in the pancreatic dorsal bud of ascl1b expression in the
mind bomb (mib-/-) mutants while nkx6.1 expression is not affected at 13
hpf. E, F Fluorescent WISH showing that the pancreatic expression of
nkx6.1 in the ventral bud is not perturbed at 34 hpf in mib-/- mutants.
The ventral (A, B, E, F) or lateral (C, D) views represent confocal
projection images with the anterior to the left. Scale bars = 40 μM. NS
nervous system. (PNG 968 kb)
Additional file 6: Figure S6. All Notch-responsive cells in the adult
pancreas are CACs. Notch active cells in Tg(Tp1:VenusPest) adult fish were
labeled with anti-GFP to visualize VenusPest (green) and the ductal marker
2F11 (red). VenusPest labeling is detected throughout the exocrine tissue
(see asterisks highlighting examples) and where it highlights the CACs
together with 2F11. In contrast, ductal structures with intense 2F11
staining do not exhibit any Venus+ (Notch on) cells. Note also the
presence of 2F11 in endocrine islet cells as previously reported [79].
(PNG 2854 kb)
Additional file 7: Figure S7. Notch-responsive terminal end duct cells/
CACs give rise to other ductal cells. Immunodetection of H2BmCherry
and ductal markers in the pancreas of adult Tg(Tp1:VenusPest);
Tg(Tp1:H2BmCherry) zebrafish. A–C H2BmCherry+ cells (red) in ductular
structures labeled with the ductal (ducts and CACs) marker 2F11 (green).
A, B separate channels of Fig. 8b–c. B, C Weak H2BmCherry labeling is
present near the extremity of a terminal (or intercalated) duct (yellow
arrows). The asterisks identify a CAC at the tip of the duct (strong
H2BmCherry labeling). D Comparison of H2BmCherry (red) with
endogenous Nkx6.1 (green) showing ductal Nkx6.1+ cells co-expressing
H2BmCherry (yellow arrows). (PNG 4967 kb)
Additional file 8: Table S1. Duct-specific genes listed by decreased
expression level. We found 293 genes corresponding to the following
“specificity” criteria: gene expression level normalized counts >1000 in duct
and <1000 in non-ductal (averaged endocrine and acinar) transcriptome
and ≥16 fold enrichment in ducts versus non-duct (averaged endocrine
and acinar), expressed in log2 ratio (≥4). Ratio is mean of normalized counts
in duct transcriptomes/mean of normalized counts in endocrine and in
acinar transcriptomes. Known ductal markers and genes involved in the
Notch pathway are highlighted in red. Novel markers and genes
involved in the Wnt pathway are highlighted in green. (DOCX 26 kb)
Additional file 9: Figure S8. Ductal expression of id2a during zebrafish
development. Whole mount fluorescent in situ hybridization showing id2a
(green) and the ductal marker sox9b (red) in a 3-dpf larva. The expression of
both genes overlaps as highlighted by yellow labeling. In addition to
expression in the intrapancreatic ducts (IPD), id2a is also expressed in
the intrahepatic (IHD). HPD hepatopancreatic ducts. (PNG 537 kb)Additional file 10: Table S2. List of the primers used in this study. The
50 nucleotides added to allow homologous recombination are indicated
in capital letters. (DOCX 12 kb)
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